The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

FDA Issues Stronger Warning About Oral Nizoral (ketoconazole)

by Elizabeth Davis on July 29, 2013 at 1:59 pm

The FDA is recommending that Nizoral (ketoconazole) tablets not be used as a first-line treatment for any fungal infections, and not used at all to treat fungal skin or nail infections.

The oral tablets can cause liver and adrenal gland damage, and can have harmful interactions with other medications, prompting the FDA to approve a labeling change and to update the recommendations for use.

The warning is only for ketoconazole oral tablets, and does not apply to topical Nizoral or ketoconazole shampoos, creams, foams, gels, or other forms applied on the skin.

Talk to your doctor or pharmacist if you have any questions or concerns about Nizoral tablets, and you can find more information in the FDA Safety Alert here.

Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.